---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-037906"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:11:18.946563+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Petros enters waiver/amendment with investors covering Dec 2023 equity awards and warrant terms

## Summary
- Waives breach from Dec 21, 2023 issuance of 348,711 shares/options; deems them Excluded Securities.
- Amends Section 4(c) of Warrants clarifying Black Scholes Value rights in Fundamental Transactions.
- Waiver and Amendment effective as of December 31, 2023, entered March 21, 2024.
- No additional consideration paid to investors; all holders of Preferred Stock and Warrants are party.

## SEC filing metadata
- accession: 0001104659-24-037906
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/0001104659-24-037906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/tm249589d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-037906
- JSON: https://secwatch.observer/filing/0001104659-24-037906.json
- Plain text: https://secwatch.observer/filing/0001104659-24-037906.txt

## Key facts
- Material Agreements
  Petros Pharmaceuticals, Inc. amended Omnibus Waiver and Amendment with the Investors (effective 2023-12-31).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: the Investors
  - Effective: 2023-12-31
  source text: On March 21, 2024, the Company entered into an Omnibus Waiver and Amendment (the “Waiver and Amendment”) with the Investors, effective as of December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/0001104659-24-037906-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.